Ethyl1-oxaspiro[2.5]octane-2-carboxylate

Catalog No.: 
ACNZFO128
CAS No.: 
6975-17-3
Molecular Formula: 
C10H16O3
Molecular Weight: 
184.24
Ethyl1-oxaspiro[2.5]octane-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$342.00InquiryInquiry
5g97%$1230.00InquiryInquiry
10g97%$1864.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl1-oxaspiro[2.5]octane-2-carboxylate
IUPAC Nameethyl 1-oxaspiro[2.5]octane-2-carboxylate
Molecular FormulaC10H16O3
Molecular Weight184.24
SMILESO=C(C1OC12CCCCC2)OCC
InChI KeyMARQMDSVINDKRX-UHFFFAOYSA-N
SynonymETHYL 1-OXASPIRO[2.5]OCTANE-2-CARBOXYLATE;ETHYL 3,3-PENTAMETHYLENEGLYCIDATE;ETHYL 2-OXASPIRO[2.5]OCTANE-1-CARBOXYLATE;Ethyl-beta-beta-pentamethyleneglycidate;1-Oxaspiro[2.5]octane-2-carboxylic acid ethyl ester;Nsc22082;1-Oxaspiro[2.5]octane-2-carboxylicacid,ethylester(6CI,7CI,8CI,9CI)
CAS No.6975-17-3

Synthetic Route by SureRoute

1. ACNZFO128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHPXV309 route compound structure diagram
    ACHPXV3091552-92-7In Stock
  4. Then
  5. ACNZFO128 route product structure diagram
    ACNZFO1286975-17-3
Inquiry

2. ACNZFO128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHPXV309 route compound structure diagram
    ACHPXV3091552-92-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNZFO128 route product structure diagram
    ACNZFO1286975-17-3
Inquiry

3. ACNZFO128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHPXV309 route compound structure diagram
    ACHPXV3091552-92-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNZFO128 route product structure diagram
    ACNZFO1286975-17-3
Inquiry

Comments (0)